General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

v3.20.4
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Convertible Preferred Stock
Series E Preferred Stock
Series E1 Preferred Stock
Common Stock
Additional Paid-In Capital
Notes Receivable
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Total
BALANCE at Dec. 31, 2017 $ 241,789                
BALANCE (in shares) at Dec. 31, 2017 79,994,884                
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]                  
Issuance of Preferred Stock $ 35,100                
Issuance of Preferred Stock (in shares) 4,097,785                
BALANCE at Dec. 31, 2018 $ 276,889                
BALANCE (in shares) at Dec. 31, 2018 84,092,669 0 0            
BALANCE at Dec. 31, 2017       $ 2 $ 2,810   $ (69,327) $ (210) $ (66,725)
BALANCE (in shares) at Dec. 31, 2017       12,971,191          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of common stock options         373       373
Exercise of common stock options (in shares)       526,898          
Vesting of restricted Common Stock         8       8
Vesting of restricted Common Stock (in shares)       5,575,000          
Stock-based compensation expense         2,965       2,965
Common Stock warrants issued         35       35
Net loss             (121,339)   (121,339)
BALANCE at Dec. 31, 2018       $ 2 6,440 $ (249) (190,666) (96) (184,569)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Other comprehensive income (loss)               114 114
BALANCE (in shares) at Dec. 31, 2018       19,352,255          
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]                  
Issuance of Preferred Stock   $ 134,667 $ 24,977            
Issuance of Preferred Stock (in shares)   13,450,703 2,494,737            
BALANCE at Sep. 30, 2019 $ 436,533                
BALANCE (in shares) at Sep. 30, 2019 100,038,109                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of common stock options         606       606
Exercise of common stock options (in shares)       902,175          
Vesting of restricted Common Stock         6       6
Vesting of restricted Common Stock (in shares)       4,221,144          
Stock-based compensation expense         3,430       3,430
Common Stock warrants issued         905       905
Issuance of Common Stock for acquisitions         3,563       3,563
Issuance of Common Stock for acquisitions (in shares)       873,203          
Repayment of notes receivable         (249) 249      
Repayment of notes receivable (in shares)       (62,610)          
Net loss             (75,769)   (75,769)
BALANCE at Sep. 30, 2019       $ 2 14,701   (266,435) 131 (251,601)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Other comprehensive income (loss)               227 $ 227
BALANCE (in shares) at Sep. 30, 2019       25,286,167          
BALANCE at Dec. 31, 2018 $ 276,889                
BALANCE (in shares) at Dec. 31, 2018 84,092,669 0 0            
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]                  
Issuance of Preferred Stock   $ 134,667 $ 24,977            
Issuance of Preferred Stock (in shares)   13,450,703 2,494,737            
BALANCE at Dec. 31, 2019 $ 436,533                
BALANCE (in shares) at Dec. 31, 2019 100,038,109 13,450,703 2,494,737           100,038,109
BALANCE at Dec. 31, 2018       $ 2 6,440 (249) (190,666) (96) $ (184,569)
BALANCE (in shares) at Dec. 31, 2018       19,352,255          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of common stock options         708       708
Exercise of common stock options (in shares)       996,753          
Vesting of restricted Common Stock       $ 1 7       8
Vesting of restricted Common Stock (in shares)       5,653,512          
Stock-based compensation expense         5,215       5,215
Common Stock warrants issued         1,038       1,038
Issuance of Common Stock for acquisitions         3,563       3,563
Issuance of Common Stock for acquisitions (in shares)       873,203          
Repayment of notes receivable         (249) $ 249      
Repayment of notes receivable (in shares)       (62,610)          
Net loss             (103,596)   (103,596)
BALANCE at Dec. 31, 2019       $ 3 16,722   (294,262) 75 (277,462)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Other comprehensive income (loss)               171 $ 171
BALANCE (in shares) at Dec. 31, 2019       26,813,113          
BALANCE at Sep. 30, 2020 $ 436,533                
BALANCE (in shares) at Sep. 30, 2020   13,450,703 2,494,737           100,038,109
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of common stock options         255       $ 255
Exercise of common stock options (in shares)       408,869          
Vesting of restricted Common Stock         6       6
Vesting of restricted Common Stock (in shares)       4,300,846          
Stock-based compensation expense         4,228       4,228
Common Stock warrants issued         43       43
Net loss             (65,027)   (65,027)
BALANCE at Sep. 30, 2020       $ 3 $ 21,254   $ (359,289) 5 (338,027)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Other comprehensive income (loss)               $ (70) $ (70)
BALANCE (in shares) at Sep. 30, 2020       31,522,828